Cargando…
Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
Resistance to various therapies, including novel immunotherapies, poses a major challenge in the management of breast cancer and is the leading cause of treatment failure. Bidirectional communication between breast cancer cells and the tumour microenvironment is now known to be an important contribu...
Autores principales: | Samuels, Mark, Cilibrasi, Chiara, Papanastasopoulos, Panagiotis, Giamas, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773878/ https://www.ncbi.nlm.nih.gov/pubmed/35053279 http://dx.doi.org/10.3390/biom12010132 |
Ejemplares similares
-
Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Cilibrasi, Chiara, et al.
Publicado: (2021) -
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
por: Agnarelli, Alessandro, et al.
Publicado: (2022) -
The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications
por: Samuels, Mark, et al.
Publicado: (2023) -
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022) -
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor
por: Agnarelli, Alessandro, et al.
Publicado: (2023)